Literature DB >> 3656114

Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node.

A Pelleg1, T Mitsuoka, E L Michelson, H Menduke.   

Abstract

ATP exerts pronounced electrophysiologic effects in the mammalian heart. The present study tested the hypothesis that the negative chronotropic action of ATP in the canine sinus node is dependent on its degradation to adenosine. Increasing doses of the following compounds were administered in the sinus nodal artery of 12 open chest dogs (either sex, 30-35 kg) anesthetized with pentobarbital (30 mg/kg i.v.): adenosine, ATP, alpha,beta methylene-ATP (AMPCPP) and beta,gamma methylene-ATP (AMPPCP). Right atrial, His bundle and right ventricular electrograms as well as Lead II ECG and systemic arterial blood pressure were monitored continuously and recorded. The depressant effects of test compounds on the sinus node were assessed from the prolongation of sinus cycle length and the duration of junctional escape rhythm which they induced. Data were used to plot dose-response curves for the four test compounds. The order of potency was adenosine greater than or equal to ATP greater than or equal to AMPPCP much greater than AMPCPP = 0. In 3 of 12 dogs the emergence of junctional escape rhythm was observed after the highest dose of either adenosine, ATP or AMPPCP. In addition, aminophylline, a selective competitive inhibitor of adenosine at P1-purinoceptor site, reduced the effects of maximal doses of adenosine, ATP and AMPPCP by 52 +/- 7, 67 +/- 8 and 72 +/- 6%, respectively (each, P less than .05; AMPPCP vs. adenosine, P less than .05). The present data indicate that the negative chronotropic action of ATP is due to its rapid catabolism to adenosine and the action of adenosine at P1-purinoceptor sites.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3656114

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope.

Authors:  M Brignole; G Gaggioli; C Menozzi; A Del Rosso; S Costa; A Bartoletti; N Bottoni; G Lolli
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

3.  Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.

Authors:  B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

Review 4.  Adenosine 5'-triphosphate's role in bradycardia and syncope associated with pulmonary embolism.

Authors:  Amir Pelleg; Edward S Schulman; Peter J Barnes
Journal:  Respir Res       Date:  2018-07-28

5.  Inhibition of Adenosine Pathway Alters Atrial Electrophysiology and Prevents Atrial Fibrillation.

Authors:  Luca Soattin; Anniek Frederike Lubberding; Bo Hjorth Bentzen; Torsten Christ; Thomas Jespersen
Journal:  Front Physiol       Date:  2020-06-12       Impact factor: 4.566

6.  The Ionotropic P2X4 Receptor has Unique Properties in the Heart by Mediating the Negative Chronotropic Effect of ATP While Increasing the Ventricular Inotropy.

Authors:  Bruno Bragança; Sílvia Nogueira-Marques; Fátima Ferreirinha; Ana Patrícia Fontes-Sousa; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.